Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Arcutis’ Zoryve (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age

WESTLAKE VILLAGE, Calif., July 09, 2024 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company...

Some Women in Their 40s Prefer to Delay Breast Cancer Screening

A considerable proportion of women aged 39 to 49 years prefer to delay breast cancer screening, especially after a decision aid (DA) intervention, according...

Hospital-Onset SARS-CoV-2 Infection During Omicron Linked to Morbidity

During the omicron era, hospital-onset severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remained associated with increased morbidity...

Psychological Risks Increased for Transgender Youth at Gender Identity Milestones

Transgender youth have an increased risk for attempting suicide or running away from home in association with gender identity milestones, with the association...

Metformin, SGLT2 Inhibitors Exhibit Significantly Lower Dementia Risk

Compared with other antidiabetic classes, metformin and sodium glucose co-transporter-2 inhibitors (SGLT2is) exhibit significantly lower dementia risk,...

Shannen Doherty Dies of Breast Cancer at 53

Actress Shannen Doherty, best known for her roles in 1990s television hits such as “Beverly Hills, 90210” and “Charmed," has died at...

Global Childhood Vaccination Rates Still Haven't Recovered from Pandemic Declines

More than four years after the pandemic began, childhood vaccination rates worldwide have yet to recover, a new report shows. The latest data, issued...

Five Cases of Bird Flu Reported in Colorado Poultry Workers

Five poultry workers in Colorado have been diagnosed with bird flu, state health officials reported Sunday. "In coordination with the Colorado Department...

AI Better at Predicting Progression to Alzheimer's Than Standard Care

An AI program has proven better than doctors at sifting through the telltale signs that indicate who with early dementia will progress to Alzheimer’s...

Supercore Issues Voluntary Worldwide Recall of Hard Steel Capsules & Gold Hard Steel Plus Liquid Due to the Presence of Sildenafil and Acetaminophen

July 12, 2024 -- Supercore Products Group is voluntarily recalling of Hard Steel Capsules & Gold Hard Steel Plus Liquid to the consumer level. FDA...

Niclosamide-based Metabolic Anticancer Drug's First Clinical Trial Target are Prostate Cancer Patients Resistant to Hormone Therapy

SEOUL, South Korea, July 11, 2024. ADM Korea, a subsidiary of Hyundai Bioscience, announced on the 8th that the first clinical trial target population...

AskBio receives FDA Fast Track and MHRA Innovation Passport Designations for AB-1005 Investigational GDNF Gene Therapy for Parkinson’s Disease

Berlin, Germany, and Research Triangle Park, N.C., USA, July 11, 2024 – Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company...

Osteoarthritis Raises Risk of Other Chronic Health Conditions

Osteoarthritis could nearly triple a person’s risk of developing a multitude of other chronic illnesses, a new two-decade study finds. People with...

Read more news...

Recently Added

Recently added consumer and prescribing information: Pyzchiva, Ahzantive, Ohtuvayre, Sofdra, Yimmugo, Iqirvo, Rytelo, mRESVIA, Bkemv, Yesafili

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Kisunla Kisunla (donanemab-azbt) is an amyloid beta-directed antibody indicated for the treatment of early symptomatic Alzheimer’s disease.
  • Ahzantive Ahzantive (aflibercept-mrbb) is a vascular endothelial growth factor (VEGF) inhibitor biosimilar to Eylea indicated for the treatment of...
  • Nypozi Nypozi (filgrastim-txid) is a leukocyte growth factor biosimilar to Neupogen indicated for the treatment of neutropenia, neutropenia...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...

More drugs in development